HIV-HCV
Coinfection Top News Articles |
|
Treatment
of Patients with HIV-HCV Coinfection: An Overview
Guidelines
for Management of HIV-HCV Coinfection |
|
 Predictors
of Sustained Treatment Response in HIV-HCV Coinfected
Patients Receiving Routine Care
6-16-2009
|
Does
HIV-HCV Coinfection Increase the Risk of
Liver Disease Progression and Worsen Clinical Outcomes?
6-9-2009
|
HIV-HCV
Coinfected and HCV Monoinfected Patients with Genotype 2-3 Respond
Equally Well to 24 Weeks of Pegylated Interferon plus
Ribavirin
6-5-2009 |
 HIV-HCV
Coinfected Individuals and Those with HIV-HBV-HCV Triple Infection
Have a Higher Risk of Death in the HAART Era
6-2-2009
|
Does
HIV-HCV Coinfection Increase the Risk of
Liver Disease Progression and Worsen Clinical Outcomes?
6-9-2009 |
HIV-HCV
Coinfected and HCV Monoinfected Patients with Genotype 2-3 Respond
Equally Well to 24 Weeks of Pegylated Interferon plus Ribavirin
6-5-2009 |
Antiviral
Agents with Activity against Both HIV and Hepatitis C
Virus
6-2-2009 |
|
Sustained
Response to Interferon-based Therapy for Hepatitis
C Reduces Risk of Liver Toxicity Due to Antiretroviral
Drugs for HIV
5-29-2009
|
HIV
Negative Individuals with Hepatitis C and HIV-HCV Coinfected
Patients Have Similar Hepatocellular Carcinoma Outcomes
5-29-2009
|
Hepatitis
C Virus Coinfection May Be a Risk Factor for Atherosclerosis
in HIV Positive Individuals
5/22/09 |
Acute
Hepatitis C Affects Neurocognitive Functioning
in People with HIV
5/22/09 |
Studies
Find No Evidence of Hepatitis C Virus Relapse or Significant Fibrosis after Spontaneous
Clearance in HIV-HCV Coinfected Individuals
5/19/09
|
 Viral
Hepatitis Coinfection Is Linked to Bone Loss in HIV Positive Women but Not
Men
4/17/09
|
 HIV
Positive and Negative Individuals with Acute or Early Chronic Hepatitis C Respond
Well to 24 Weeks of Pegylated Interferon plus Ribavirin
4/10/09 |
 Successful
Antiretroviral Therapy May Increase T-cell Response against Hepatitis C Virus
in HIV-HCV Coinfected Individuals
4/10/09 |
 Studies
Shed More Light on Acute Hepatitis C among HIV Positive
Men in the U.S. and Europe
4/07/09 |
 Outcomes
of Liver Transplantation in HIV Positive Recipients Coinfected
with Hepatitis B or C
3/24/09 |
Virological
Response Can Help Determine Optimal Duration of Pegylated
interferon/ribavirin Treatment for HIV-HCV
Coinfected Patients
3/20/09 |
 Daniel Fierer Speaks at HIV-HCV
Coinfection Forum in San Francisco Tuesday Night
3/17/09 |
 Studies
Look at Liver Fibrosis in HIV-HCV and HIV-HBV
Coinfected People
3/13/09 |
Studies
from Europe and the U.S. Provide Further Information on Sexual Transmission of
Hepatitis C Virus among HIV Positive Men
3/10/09 |
Without
HAART, HIV Infection Accelerates Hepatitis C Disease Progression in Coinfected
Individuals
3/06/09 |
 Uninterrupted HAART, more than Hepatitis C Treatment,
Predicts Survival in HIV-HCV Coinfected Patients
3/06/09 |
High HCV Viral Load Is Associated with an Increased
Risk of Death in HIV-HCV Coinfected Individuals
3/03/09 |
Adequate
Ribavirin Level Promotes Sustained Response to Interferon-based Therapy for HIV-HCV
Coinfected Patients
2/20/09
|
HIV-HCV
Coinfected Women May Experience More Pegylated Interferon and Ribavirin
Side Effects than Men
2/20/09 |
HIV-HCV
Coinfected Patients Experience Longer Hospitalization, More Emergency
Visits, and Greater Disability than People with HIV Alone
2/17/09 |
Despite
Infrequent "Blips," Tenofovir (Viread)
Provides Good Hepatitis B Virus Suppression HIV-HBV Coinfected Individuals
2/17/09 |
Complete
Early Response to Pegylated Interferon/ribavirin Predicts Sustained Response in
HIV-HCV Coinfected Patients: SLAM-C
2/17/09 |
Human
Genetic Variation Associated with Good T-cell Response Predicts Successful Treatment
in HIV-HCV Coinfected Patients
2/17/09 |
 Does
Early Treatment for HIV Prevent Liver Fibrosis in HIV-HCV
Coinfected Patients?
1/30/2009
|
 Pegylated
Interferon Alfa-2a (Pegasys) and Alfa-2b (PegIntron) Work Equally Well
in HIV-HCV Coinfected Patients
1/23/2009
|
 Maternal Neutralizing Antibodies Do Not Prevent Mother-to-Child
HCV Transmission from HIV-HCV Coinfected Mothers
1/20/2009 |
 GBV-C,
SEN Virus, and Occult HBV Infection in HIV-HCV
Coinfected Patients
1/10/2009 |
HIV
Positive People May Be Slow to Develop HCV Antibodies during Acute Infection,
HCV RNA Test More Accurate
1/05/2009 |
 Advanced
Liver Disease in People with HIV
12/10/08 |
 Blood
Lipid Levels and Insulin Resistance Predict Response to Interferon-based Therapy
in HIV-HCV Coinfected Patients
12/05/08 |
 Ritonavir
(Norvir), but Not Abacavir (Ziagen), Adversely Influences Hepatitis
C Treatment in HIV-HCV Coinfected Patients
11/25/08 |
 Does
Antiretroviral Therapy Reduce Ribavirin Levels in HIV-HCV
Coinfected Individuals?
11/25/08
|
Partial
Rapid Virological Response Predicts Sustained Response in HCV-HIV
Coinfected Patients, APRICOT Analysis Shows
11/21/08 |
Outcomes
of Acute Hepatitis C Virus Infection in People with HIV
11/21/08 |
Liver
Fibrosis Progression in HIV-HCV Coinfected Individuals
11/11/08 |
Liver
Fibrosis Progression in HIV-HCV Coinfected Individuals
11/07/08 |
 Comparison
of Non-invasive Biomarkers for Predicting Liver Fibrosis in HIV-HCV
Coinfected Individuals
10/24/08 |
 Response
to Pegylated Interferon plus Ribavirin in
HIV-HCV Coinfected Patients with HCV Genotype
4
10/21/08 |
 Lower
CD4 Count Linked to Increased Risk of Liver Cancer
in HIV Positive People, Especially Those with Hepatitis B Coinfection
10/10/08 |
 Detectable
HCV in Peripheral Blood Cells after Interferon-based
Therapy Predicts Relapse in HIV-HCV Coinfected
Patients
10/07/08 |
 Hepatitis
C Virus Spontaneous Clearance, Viral Load, and Genotype Distribution in HIV-HCV
Coinfected Patients in Europe
10/03/08 |
Use
of HIV Protease Inhibitors Does Not Promote Hepatitis C Virus Protease Mutations
in HIV-HCV Coinfected Individuals
9/26/08 |
 HIV-related
Immune Suppression Does Not Promote Genetic Divergence of Hepatitis C Virus in
HIV-HCV Coinfected Individuals
9/23/08 |
 The
Impact of Hepatitis C Virus Coinfection on
HIV-related Kidney Disease
9/23/08 |
Liver
Fibrosis Progression Rates in HCV Monoinfected and HIV-HCV
Coinfected Individuals
9/16/08 |
Higher
Ribavirin Concentration is Associated with Improved Treatment Response
in HIV-HCV Coinfected Individuals
9/12/2008 |
 HIV-HCV
Coinfected Pregnant Women More Likely to Have Detectable HIV despite
HAART, Raising Risk of Mother-to-child HIV Transmission
9/5/08 |
 Milk
Thistle Compound Silymarin Safe and Potentially Effective for HIV-HCV
Coinfected Patients on HAART
8/31/2008 |
HIV-HCV
Coinfected Patients May Have Fewer Psychiatric Comorbidities than People
with HCV Alone
8/26/2008 |
HIV
Positive Individuals Are at Higher Risk of Occult Hepatitis B Virus Infection,
but Occult Hepatitis C Virus Is Rare
8/26/2008 |
Risk
of Mother-to-Child HIV and HCV Transmission from Coinfected
Pregnant Women
8/22/2008 |
Are
HIV Positive People More Likely to Relapse
after Completion of Hepatitis C Treatment
with Pegylated Interferon plus Ribavirin
8/22/2008 |
Further
Evidence of Sexual Transmission of Hepatitis C Virus
among HIV Positive Men Who Have Sex with Men
8/19/2008 |
Do
HIV-HCV Coinfected Patients Respond Better
to Pegasys or PegIntron as Part of Combination Therapy for Chronic Hepatitis C?
8/19/2008 |
HIV-HCV
Coinfected Individuals May Have a Higher Risk of Cardiovascular Disease
than HIV Positive People without Hepatitis C
8/15/2008 |
Body
Weight Affects Relapse Rates in Latinos with Genotype 2/3 Hepatitis C Treated
with Pegylated Interferon Alfa-2a (Pegasys) plus Ribavirin
8/15/2008 |
Hepatitis
C Virus Kinetics during the First 24 Hours of Treatment Predicts Rapid and End-of-treatment
Response in HIV-HCV Coinfected Patients
8/08/2008 |
Severe
Liver Fibrosis during Acute HCV Infection in HIV Positive
Men Who Have Sex with Men
8/05/2008 |
Review
Articles Provide Overview of Epidemiology and Management
of HIV-HCV Coinfection
8/01/08 |
Pharmacokinetics
of Lopinavir/ritonavir (Kaletra) in HIV-HCV Coinfected
Patients with or without Liver Cirrhosis
7/29/08 |
HIV-HCV
Coinfected People Taking Modern HAART Regimens Show No Evidence of
Liver Mitochondrial Toxicity
7/29/08 |
Biomarker
Tests Accurately Predict Extent of Liver Fibrosis in
HIV-HCV Coinfected Individuals
7/22/08 |
Serum
Alpha-fetoprotein Level Predicts Sustained Response to Hepatitis
C Treatment in HIV Positive Patients
7/22/08 |
Can
Rapid Virological Response Predict Sustained Response to Pegylated Interferon
plus Ribavirin in HIV-HCV Coinfected Patients?
7/18/08
|
HIV-HCV
Coinfection Does Not Impair CD4 Cell Recovery after Starting Antiretroviral
Therapy
7/11/08 |
FDA
Revises Process for Responding to Drug Approval Applications
from Pharmaceutical Companies
7/11/08 |
Is
Pegylated interferon Monotherapy the Best
First-line Treatment for Acute Hepatitis C in HIV Positive Individuals?
7/08/08 |
HCV-Related
Liver Fibrosis Is More Severe in HIV Positive Individuals Despite Antiretroviral
Therapy
6/24/08 |
Liver
Biopsies Reveal No Evidence of Mitochondrial Damage in HIV-HCV
Coinfected Individuals on HAART
6/13/08 |
|
HAART
May Reduce Liver Inflammation in HIV-HCV Coinfected Patients
with High CD4 Cell Count
FDA-approved
Combination Therapies for Chronic HCV Infection
